Immunomedics (IMMU) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WWS who wrote (190)	9/25/1997 5:41:00 PM
From: David B. Higgs	of 371

According to press releases today, Paul Herron, Director of Finance has left IMMU to become CFO of Sunpharm Corp. The press release put out by Sunpharm stated Herron's responsibilities at IMMU included "financial operations, accounting, SEC reporting, cash management, purchasing, information resources, insurance and investor relations." Does this leave anyone with enough business experience to run the company? With less than 100 employees, does Dr. Goldenberg want to bring in new talent to replace Herron or does he now give greater consideration to a buyout? Can anyone add insight to the impact of Herron leaving? Thanks Dave

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next